NCT02977754View on ClinicalTrials.gov

18F-FDG PET in HCC Patients Candidate to Treatment With Sorafenib

CompletedOBSERVATIONAL
Enrollment

13

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

March 31, 2019

Conditions
HCC
Interventions
OTHER

This is an observational study

Imaging

Trial Locations (1)

20089

Istituto Clinico Humanitas, Rozzano

All Listed Sponsors
lead

Istituto Clinico Humanitas

OTHER

NCT02977754 - 18F-FDG PET in HCC Patients Candidate to Treatment With Sorafenib | Biotech Hunter | Biotech Hunter